C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/01 (2006.01) A61K 31/70 (2006.01) A61K 39/205 (2006.01) A61K 48/00 (2006.01) C07K 14/145 (2006.01) C12N 15/86 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2233983
Described herein is a recombinant adenovirus adapted to raise in a mammal an immune response to rabies, the adenovirus having a functionally disrupted e1 region and comprising an expression cassette in which DNA coding for rabies glycoprotein is linked operably with expression controls functional in a eukaryotic host.
On décrit un adénovirus recombiné, conçu pour augmenter, chez un mammifère, une réponse immune à la rage, cet adénovirus présentant une région e1 interrompue fonctionnellement et comprenant une cassette d'expression dans laquelle l'ADN codant pour la glycoprotéine de la rage est lié de manière opérante à des commandes d'expression fonctionnelles chez un hôte eucaryote.
Graham Frank L.
Prevec Ludvik
Yarosh Oksana K.
Gastle And Associates
Microbix Biosystems Inc.
LandOfFree
Rabies recombinant adenovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rabies recombinant adenovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rabies recombinant adenovirus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1411714